{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T14:09:08Z","timestamp":1785247748668,"version":"3.55.0"},"reference-count":17,"publisher":"Knowledge E DMCC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Ophthalmic Vis Res"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/2008-322x.176905","type":"journal-article","created":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T05:34:55Z","timestamp":1455860095000},"page":"484","source":"Crossref","is-referenced-by-count":14,"title":["Intravitreal bevacizumab for management of choroidal osteoma without choroidal neovascularization"],"prefix":"10.18502","volume":"10","author":[{"given":"MohammadrezaFazel","family":"Najafabadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FarhadFazel","family":"Najafabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SeyyedMoien","family":"Hendimarjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasaman","family":"Zarrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7770","reference":[{"key":"key-10.4103\/2008-322X.176905-1","first-page":"1081","volume-title":"Choroidal osteoma with choroidal neovascular membrane: Successful treatment with intravitreal bevacizumab","author":"Pandey","year":"2010","journal-title":"Clin Ophthalmol"},{"key":"key-10.4103\/2008-322X.176905-2","first-page":"17","volume-title":"Choroidal osteoma","author":"Shields","year":"1988","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/2008-322X.176905-3","first-page":"1731","volume-title":"Dramatic response of choroidal neovascularization associated with choroidal osteoma to the intravitreal injection of bevacizumab (Avastin)","author":"Ahmadieh","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/2008-322X.176905-4","first-page":"945","volume-title":"Intravitreal bevacizumab in the management of subretinal fluid associated with choroidal osteoma","author":"Song","year":"2010","journal-title":"Retina"},{"key":"key-10.4103\/2008-322X.176905-5","first-page":"1337","volume-title":"A long-term follow-up of choroidal osteoma","author":"Aylward","year":"1998","journal-title":"ArchOphthalmol"},{"key":"key-10.4103\/2008-322X.176905-6","first-page":"1658","volume-title":"Factors predictive of tumor growth, tumor decalcification, choroidal neovascularization, and visual outcome in 74 eyes with choroidal osteoma","author":"Shields","year":"2005","journal-title":"ArchOphthalmol"},{"key":"key-10.4103\/2008-322X.176905-7","first-page":"1004","volume-title":"Fundus autofluorescence imaging findings in choroidal osteoma","author":"Ascaso","year":"2011","journal-title":"Retina"},{"key":"key-10.4103\/2008-322X.176905-8","doi-asserted-by":"crossref","unstructured":"Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 2006;113:363-372.e5.","DOI":"10.1016\/j.ophtha.2005.11.019"},{"key":"key-10.4103\/2008-322X.176905-9","first-page":"1","volume-title":"Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration","author":"Bashshur","year":"2006","journal-title":"AmJ Ophthalmol"},{"key":"key-10.4103\/2008-322X.176905-10","first-page":"4569","volume-title":", Scott IU.Intravitreal bevacizumab for choroidal neovascularization caused by AMD (IBeNA Study): Results of a phase 1 dose-escalation study","author":"Costa","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.176905-11","first-page":"1368","volume-title":"Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia","author":"Nguyen","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/2008-322X.176905-12","first-page":"428","volume-title":"Choroidal osteoma","author":"Gass","year":"1978","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/2008-322X.176905-13","first-page":"438","volume-title":"Bilateral choroidal osteoma with optic atrophy","author":"Murthy","year":"2010","journal-title":"J AAPOS"},{"key":"key-10.4103\/2008-322X.176905-14","first-page":"1327","volume-title":"Choroidal osteoma: Observations from a community setting","author":"Browning","year":"2003","journal-title":"Ophthalmology"},{"key":"key-10.4103\/2008-322X.176905-15","first-page":"100","volume-title":"Intravitreal bevacizumab for choroidal neovascularization secondary to choroidal osteoma","author":"Song","year":"2009","journal-title":"Acta Ophthalmol"},{"key":"key-10.4103\/2008-322X.176905-16","first-page":"1850","volume-title":"Ranibizumab for the treatment of neovascular age-related macular degeneration: A review","author":"Kourlas","year":"2007","journal-title":"Clin Ther"},{"key":"key-10.4103\/2008-322X.176905-17","first-page":"1745","volume-title":"Intravitreal ranibizumab in a patient with choroidal neovascularization secondary to choroidal osteoma","author":"Song","year":"2009","journal-title":"Eye (Lond)"}],"container-title":["Journal of Ophthalmic and Vision Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T14:50:24Z","timestamp":1734447024000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jovr.org\/text.asp?2015\/10\/4\/484\/176905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"alternative-id":["176905"],"URL":"https:\/\/doi.org\/10.4103\/2008-322x.176905","relation":{},"ISSN":["2008-322X"],"issn-type":[{"value":"2008-322X","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}